The All-Oral Combination of Revumenib, Decitabine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia (SAVE)

Issa GC, et al.

Citation

J Clin Oncol. 2026 Jun 11:101200JCO2601159. Online ahead of print.

PMID

42272166